Serum concentrations of methaqualone after repeated oral doses of a combination formulation to human subjects.
Concentrations of methaqualone have been measured in the serum of five male human subjects receiving five consecutive evening doses of a combination formulation containing methaqualone (250 mg), carbromal (300 mg) and benactyzine (0.33 mg) in each tablet. After administration of the first dose, mean peak serum concentrations of methaqualone (1.2 mug/ml) occurred at 3 h. After obtaining peak levels, mean concentrations of methaqualone declined rapidly during the next 6 h and thereafter more slowly during the next 18 h. After administration of the last (fifth) dose, mean peak serum concentrations of methaqualone (1.9 mug/ml; 1.5 mug/ml above the predose level) occurred at 2 h. After attaining peak levels, mean concentrations of methaqualone declined rapidly during the next 6 h, and thereafter more slowly, with a half-life of approximately 10 h. Mean concentrations of methaqualone in serum samples 24 h after the second, third, fourth or fifth doses were not significantly different (0.3 mug/ml - 0.6 mug/ml) during this period of dosing. This suggests that significant accumulation of methaqualone in the serum did not occur during a period of five consecutive evening doses of the combination formulation.
D000284:Administration, Oral; D000328:Adult; D001535:Benactyzine / Q000008:administration & dosage; D004338:Drug Combinations; D006207:Half-Life; D006801:Humans; D008297:Male; D008702:Methaqualone / Q000008:administration & dosage / Q000097:blood*; D014508:Urea / Q000008:administration & dosage
D004338:Drug Combinations; D001535:Benactyzine; D008702:Methaqualone; D014508:Urea